Strategies to improve HIV treatment adherence in developed countries: clinical management at the individual level

Maithe Enriquez&sup1;, David S McKinsey&sup2;&sup1;School of Nursing, University of Missouri-Kansas City and Division of Infectious Diseases, Truman Medical Center Hospital Hill, &sup2;School of Medicine, Division of Infectious Diseases, University of Kansas and Divis...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Enriquez M, McKinsey DS
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2011
Materias:	Immunologic diseases. Allergy RC581-607
Acceso en línea:	https://doaj.org/article/76156b6fcc9e45b9909c0691f54a3b33
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:76156b6fcc9e45b9909c0691f54a3b33
record_format	dspace
spelling	oai:doaj.org-article:76156b6fcc9e45b9909c0691f54a3b332021-12-02T05:10:01ZStrategies to improve HIV treatment adherence in developed countries: clinical management at the individual level1179-1373https://doaj.org/article/76156b6fcc9e45b9909c0691f54a3b332011-05-01T00:00:00Zhttp://www.dovepress.com/strategies-to-improve-hiv-treatment-adherence-in-developed-countries-c-a7473https://doaj.org/toc/1179-1373Maithe Enriquez&sup1;, David S McKinsey&sup2;&sup1;School of Nursing, University of Missouri-Kansas City and Division of Infectious Diseases, Truman Medical Center Hospital Hill, &sup2;School of Medicine, Division of Infectious Diseases, University of Kansas and Division of Infectious Diseases, Research Medical Center, Kansas City, MO, USAAbstract: Remarkable advances in the treatment of human immunodeficiency virus (HIV) disease have been blunted by widespread suboptimal adherence (ie, nonadherence), which has emerged as a major barrier to achieving the primary goal of antiretroviral (ARV) therapy: suppression of HIV viral load. Nonsuppressed HIV viral load is associated with drug resistance, increased morbidity and mortality, and a higher risk of person-to-person HIV transmission. For HIV-infected individuals who are failing HIV treatment due to nonadherence, becoming adherent is a life-saving behavior change. However, overcoming nonadherence is one of the most daunting challenges in the successful management of HIV disease. The purpose of this paper is to provide clinicians with a better understanding of nonadherence to ARV treatment and to review the various factors that have been associated with either adherence or nonadherence. Strategies are presented that may help the nonadherent individual become ready to take HIV medications as prescribed.Keywords: noncompliance, treatment failure, AIDSEnriquez MMcKinsey DSDove Medical PressarticleImmunologic diseases. AllergyRC581-607ENHIV/AIDS: Research and Palliative Care, Vol 2011, Iss default, Pp 45-51 (2011)
institution	DOAJ
collection	DOAJ
language	EN
topic	Immunologic diseases. Allergy RC581-607
spellingShingle	Immunologic diseases. Allergy RC581-607 Enriquez M McKinsey DS Strategies to improve HIV treatment adherence in developed countries: clinical management at the individual level
description	Maithe Enriquez&sup1;, David S McKinsey&sup2;&sup1;School of Nursing, University of Missouri-Kansas City and Division of Infectious Diseases, Truman Medical Center Hospital Hill, &sup2;School of Medicine, Division of Infectious Diseases, University of Kansas and Division of Infectious Diseases, Research Medical Center, Kansas City, MO, USAAbstract: Remarkable advances in the treatment of human immunodeficiency virus (HIV) disease have been blunted by widespread suboptimal adherence (ie, nonadherence), which has emerged as a major barrier to achieving the primary goal of antiretroviral (ARV) therapy: suppression of HIV viral load. Nonsuppressed HIV viral load is associated with drug resistance, increased morbidity and mortality, and a higher risk of person-to-person HIV transmission. For HIV-infected individuals who are failing HIV treatment due to nonadherence, becoming adherent is a life-saving behavior change. However, overcoming nonadherence is one of the most daunting challenges in the successful management of HIV disease. The purpose of this paper is to provide clinicians with a better understanding of nonadherence to ARV treatment and to review the various factors that have been associated with either adherence or nonadherence. Strategies are presented that may help the nonadherent individual become ready to take HIV medications as prescribed.Keywords: noncompliance, treatment failure, AIDS
format	article
author	Enriquez M McKinsey DS
author_facet	Enriquez M McKinsey DS
author_sort	Enriquez M
title	Strategies to improve HIV treatment adherence in developed countries: clinical management at the individual level
title_short	Strategies to improve HIV treatment adherence in developed countries: clinical management at the individual level
title_full	Strategies to improve HIV treatment adherence in developed countries: clinical management at the individual level
title_fullStr	Strategies to improve HIV treatment adherence in developed countries: clinical management at the individual level
title_full_unstemmed	Strategies to improve HIV treatment adherence in developed countries: clinical management at the individual level
title_sort	strategies to improve hiv treatment adherence in developed countries: clinical management at the individual level
publisher	Dove Medical Press
publishDate	2011
url	https://doaj.org/article/76156b6fcc9e45b9909c0691f54a3b33
work_keys_str_mv	AT enriquezm strategiestoimprovehivtreatmentadherenceindevelopedcountriesclinicalmanagementattheindividuallevel AT mckinseyds strategiestoimprovehivtreatmentadherenceindevelopedcountriesclinicalmanagementattheindividuallevel
_version_	1718400537280380928

Strategies to improve HIV treatment adherence in developed countries: clinical management at the individual level

Ejemplares similares